Clinical Trials Browser

Phase 1 × Interventional × LY2510924 × Clear all

NCT02652871 2019-11-15

LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myeloid, Acute

NCT02737072 2019-08-12

A Study of LY2510924 and Durvalumab in Participants With Solid Tumors

Phase 1 Terminated

9 enrolled 13 charts

Other solid neoplasm

Solid Tumor